Cargando…
A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
Resveratrol is a polyphenol with a well-established beneficial effect on dyslipidemia and hyperuricemia in preclinical experiments. Nonetheless, its efficacy and dose–response relationship in clinical trials remains unclear. This study examined whether resveratrol supplement improves the serum lipid...
Autores principales: | Zhou, Yuqing, Zeng, Yupeng, Pan, Zhijun, Jin, Yufeng, Li, Qing, Pang, Juan, Wang, Xin, Chen, Yu, Yang, Yan, Ling, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921501/ https://www.ncbi.nlm.nih.gov/pubmed/36771199 http://dx.doi.org/10.3390/nu15030492 |
Ejemplares similares
-
Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose–response manner in subjects with dyslipidemia
por: Zhang, Hanyue, et al.
Publicado: (2020) -
Dose-dependent effects of anthocyanin supplementation on platelet function in subjects with dyslipidemia: A randomized clinical trial
por: Tian, Zezhong, et al.
Publicado: (2021) -
Evaluation of Saccharin and Resveratrol as Extrinsic Markers of Small-Quantity Lipid-Based Nutrient Supplement Consumption in Healthy Women
por: Zyba, Sarah J, et al.
Publicado: (2021) -
Measurement of Saccharin and trans-Resveratrol Metabolites
in Urine as Adherence Markers for Small
Quantity Lipid-Based Nutrient Supplement Consumption
por: Weinborn, Valerie, et al.
Publicado: (2021) -
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidemia and inflammation
por: Paul, Sudip, et al.
Publicado: (2021)